| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |